Patricia Buehler, MD, MPH, (l) and John Garland.

BEND, Ore.—Osheru, a medical device company specializing in innovative solutions for skin surgery, has completed a $4.7 million funding round to accelerate the development and commercialization of its Ziplyft device for blepharoplasty surgery. The round was led by individuals and family offices, including investment from Nike co-founder Phil Knight, the company stated. Additional investors include the Oregon ToughTech BreakThrough Fund, managed by ONAMI for Business Oregon, and SOPHINCAP, the corporate venture fund of Laboratorios Sophia, an international ophthalmology company and leader in research and innovation. The company noted that the resulting oversubscribed funding round reflects robust investor confidence in Osheru’s approach to eyelid surgery.

“This $4.7 million funding marks a pivotal moment for Osheru,” said CEO Patricia Buehler, MD, MPH. “It demonstrates the strong confidence in Ziplyft from both the medical community and investors, validating our vision to revolutionize blepharoplasty with cutting-edge technology.”

Osheru also announced the appointment of John Garland as chief commercial officer, adding that as a veteran executive in the ophthalmology industry, Garland brings decades of experience in medical device innovation and commercialization. The company noted that Garland’s strategic leadership and passion for improving the surgeon and patient experience will be pivotal as Osheru accelerates its commercialization efforts.

“Joining Osheru to launch Ziplyft is an exciting opportunity,” said Garland. “This innovative technology addresses key challenges in blepharoplasty, promising improved outcomes for patients and enhanced capabilities for surgeons. I'm eager to drive its growth and advance the field of eyelid surgery.”